{"nct_id":"NCT02988440","title":"Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients","status":"COMPLETED","status_verified_date":"2020-09","start_date":"2017-04-20","start_date_type":"ACTUAL","primary_completion_date":"2020-02-27","primary_completion_date_type":"ACTUAL","completion_date":"2020-02-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}